Spindle-shaped cells derived from giant-cell tumor of bone support differentiation of blood monocytes to osteoclast-like cells
- 1 July 2000
- journal article
- research article
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 18 (4) , 647-654
- https://doi.org/10.1002/jor.1100180418
Abstract
Spindle‐shaped cells were established from four giant‐cell tumors of bone. When human blood monocytes were co‐cultured with these cells, multinucleated giant‐cell formation of monocytes was induced. Intriguingly, even when a filter (pore size: 0.45 μm) was interposed between monocytes and the spindleshaped cells, polykaryocytes also appeared. These multinucleated giant cells were positive for tartrateresistant acid phosphatase, expressed calcitonin receptor, and showed bone‐resorption activity, characteristics of osteoclast‐like cells. These findings indicate that soluble factors secreted from these cells play an important role in osteoclast‐like cell formation from blood monocytes. These data additionally suggest that these cells support osteoclast‐like cell formation in giant‐cell tumors of bone. The cells also expressed mannose receptor, fibronectin, receptor activator of nuclear factorkB, and several cytokine mRNAs, including interleukin‐6, receptor activator of nuclear factorkB ligand/osteoclast differentiation factor/osteoprotegerin ligand, and macrophage colony‐stimulating factor, However, all of these molecules except receptor activator of nuclear factorkB ligand mRNA could also be detected in control HeLa and CV‐1 cells. Although the soluble receptor activator of nuclear factorkB ligand has not been found under physiological conditions, it is possible that it is cleaved by cellular proteases and the truncated receptor activator of nuclear factorkB is released from cells. Identification of the soluble factors capable of inducing osteoclast formation from blood monocytes is a pressing problem to be solved.Keywords
This publication has 19 references indexed in Scilit:
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Induction of Human Osteoclast-like Cells by Treatment of Blood Monocytes with Anti-Fusion Regulatory Protein-1/CD98 Monoclonal AntibodiesJournal of Bone and Mineral Research, 1998
- Production and characterization of osteoclast-selective monoclonal antibodies that distinguish between multinucleated cells derived from different human tissues.Journal of Histochemistry & Cytochemistry, 1991
- The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor geneNature, 1990
- Calcitonin Receptors of Human OsteoclastomaHormone and Metabolic Research, 1987
- Human giant cell tumors of bone identification and characterization of cell types.Journal of Clinical Investigation, 1987
- Characterization of Cells from Human Giant Cell Tumors of BoneClinical Orthopaedics and Related Research, 1986
- Identification of Human Osteoclasts with Monoclonal AntibodiesNew England Journal of Medicine, 1985
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979
- Growth and Maintenance of Human Giant-cell Bone Tumors (Osteoclastomas) in Continuous CultureOncology, 1970